Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
9.76
+0.41 (4.33%)
Oct 28, 2026, 4:00 PM EDT - Market closed
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of $269.67 million as of October 28, 2026. Its market cap has decreased by 2.07% in one year.
Market Cap
269.67M
Enterprise Value
178.35M
1-Year Change
-2.07%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from $10.33M to $269.67M, an increase of 2,510.35%. That is a compound annual growth rate of 34.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 269.67M | -22.09% |
| Dec 30, 2025 | 346.13M | 92.86% |
| Dec 30, 2024 | 179.47M | 14.25% |
| Dec 29, 2023 | 157.08M | 11.76% |
| Dec 30, 2022 | 140.55M | 27.27% |
| Dec 30, 2021 | 110.43M | -52.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 294.96M |
| SAB Biotherapeutics | 291.16M |
| Fulcrum Therapeutics | 286.11M |
| Rocket Pharmaceuticals | 283.22M |
| Vogenx | 281.06M |
| Century Therapeutics | 271.61M |
| Bicycle Therapeutics | 271.57M |
| Q32 Bio | 269.71M |